Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with radiologically proven brain metastases secondary to non-small cell lung cancer
Received previous whole brain radiation therapy and none, 1 or 2 prior systemic therapy for the treatment of advanced/metastatic non-small cell lung cancer
You may not be if
Patients with brainstem lesions, spinal cord compression. carcinomatous meningitis, or leptomeningeal disease.
Brain metastases \>4 cm in any linear direction
Intracranial or intratumoral hemorrhage
Clareo Health | Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases
